Eurocine Vaccines has appointed Dr Anna-Karin Maltais to the positions of CSO and Head of Research and Development. The company's former CSO, Professor Jorma Hinkula, has returned to his position as professor at the University of LinkÃ¶ping. He will remain an advisor to Eurocine Vaccines.
Maltais has previously worked as Vice President, Corporate Development at Cyto Pulse Sciences, a US company focusing on vaccine administration by electroporation. She has been managing clinical trials of new vaccines for a number of years and has experience in vaccine development. She has been working at Eurocine Vaccines since 2011.
In addition, Eurocine's Business Development Manager since 2009, Emma Berglund Eng, has been promoted to CBO and Head of Business Development. Burglund Eng has several years of experience in business development and licensing from Biovitrum and Avaris.